Cleared Traditional

K211125 - Novum IQ Syringe Pump

K211125 is the FDA 510(k) clearance for Novum IQ Syringe Pump by Baxter Healthcare Corporation. It is a Class 2 General Hospital device (product code FRN) cleared through the Traditional 510(k) pathway after a 502-day FDA review.

K211125 · Baxter Healthcare Corporation · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 2022
Decision
502d
Days
Class 2
Risk

K211125 is an FDA 510(k) clearance for the Novum IQ Syringe Pump. Classified as Pump, Infusion (product code FRN), Class II - Special Controls.

Submitted by Baxter Healthcare Corporation (Deerfield Lake, US). The FDA issued a Cleared decision on August 30, 2022 after a review of 502 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5725 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind General Hospital submissions.

View all Baxter Healthcare Corporation devices

Submission Details

510(k) Number K211125 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 15, 2021
Decision Date August 30, 2022
Days to Decision 502 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
373d slower than avg
Panel avg: 129d · This submission: 502d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code FRN Pump, Infusion
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5725
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - FRN Pump, Infusion

All 435
Devices cleared under the same product code (FRN) and FDA review panel - the closest regulatory comparables to K211125.
Spectrum IQ Infusion System with Dose IQ Safety Software
K230041 · Baxter Healthcare Corporation · Mar 2023
Avoset Infusion Pump System
K213744 · Eitan Medical , Ltd. · Mar 2023
Spectrum IQ Infusion System with Dose IQ Safety Software
K222048 · Baxter Healthcare Corporation · Sep 2022
FreedomEdge Syringe Infusion System
K214045 · Repro-Medical System, Inc., Dba Koru Medical Systems · Apr 2022
Spectrum IQ Infusion System with Dose IQ Safety Software
K220417 · Baxter Healthcare Corporation · Apr 2022
Agilia VP Infusion System, Agilia VP MC WIFI Infusion Pump, Volumat Lines Administration Sets, Agilia Link, Agilia Duo
K210073 · Fresenius Kabi AG · Mar 2022